These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 31300328)

  • 1. [Tolerance of hypofractionated stereotactic radiotherapy for hepatic tumours].
    Le Bon M; Lapeyre M; Moreau J; Bellière-Calandry A; Pezet D; Abergel A; Bellini R; Kwiatkowski F; Verrelle P; Martin F; Benoît C
    Cancer Radiother; 2019 Sep; 23(5):385-394. PubMed ID: 31300328
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Stereotactic body radiation therapy in the management of liver tumours].
    Jacob J; Nguyen F; Deutsch E; Mornex F
    Cancer Radiother; 2014 Oct; 18(5-6):486-94. PubMed ID: 25195113
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Stereotactic lung radiotherapy: Technical setting up on Novalis Tx
    Bellière-Calandry A; Dupic G; Magnier F; Chassin V; Dedieu V; Lapeyre M
    Cancer Radiother; 2017 Jun; 21(4):291-300. PubMed ID: 28522279
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [An analysis of 20 consecutive patients treated with stereotactic body radiotherapy on Novalis Tx(®) for stage I non-small-cell lung cancer].
    Guillerme F; Clavier JB; Schumacher C; Falcoz PE; Bourrhala K; Santelmo N; Hassler S; Schott R; Quoix E; Massard G; Noël G
    Cancer Radiother; 2013; 17(4):272-81. PubMed ID: 23712043
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Stereotactic body radiation therapy for hepatocellular carcinoma: Results from a retrospective multicentre study].
    Scher N; Janoray G; Riet FG; Le Bayon AG; Debbi K; Lévy S; Louisot P; Garaud P; Chajon E; Barillot I; Salamé É; de Crevoisier R; Chapet S; Calais G
    Cancer Radiother; 2019 Apr; 23(2):104-115. PubMed ID: 30952560
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hypofractionated stereotactic radiotherapy for challenging brain metastases using 36 Gy in six fractions.
    Dumont Lecomte D; Lequesne J; Geffrelot J; Lesueur P; Barraux V; Loiseau C; Lacroix J; Leconte A; Émery É; Thariat J; Stefan D
    Cancer Radiother; 2019 Dec; 23(8):860-866. PubMed ID: 31677901
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Safety and Efficacy of Accelerated Hypofractionation and Stereotactic Body Radiation Therapy for Hepatocellular Carcinoma Patients With Varying Degrees of Hepatic Impairment.
    Nabavizadeh N; Waller JG; Fain R; Chen Y; Degnin CR; Elliott DA; Mullins BT; Patel IA; Dyer BA; Fakhoury K; Naugler WE; Farsad K; Tanyi JA; Fuss M; Thomas CR; Hung AY
    Int J Radiat Oncol Biol Phys; 2018 Mar; 100(3):577-585. PubMed ID: 29413273
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phase I study of individualized stereotactic body radiotherapy for hepatocellular carcinoma and intrahepatic cholangiocarcinoma.
    Tse RV; Hawkins M; Lockwood G; Kim JJ; Cummings B; Knox J; Sherman M; Dawson LA
    J Clin Oncol; 2008 Feb; 26(4):657-64. PubMed ID: 18172187
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Helical IMRT-Based Stereotactic Body Radiation Therapy Using an Abdominal Compression Technique and Modified Fractionation Regimen for Small Hepatocellular Carcinoma.
    Chen YX; Zhuang Y; Yang P; Fan J; Zhou J; Hu Y; Zhu WC; Sun J; Zeng ZC
    Technol Cancer Res Treat; 2020; 19():1533033820937002. PubMed ID: 32613904
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phase I/II trial of helical IMRT-based stereotactic body radiotherapy for hepatocellular carcinoma.
    Kim JW; Kim DY; Han KH; Seong J
    Dig Liver Dis; 2019 Mar; 51(3):445-451. PubMed ID: 30503296
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predictors of toxicity associated with stereotactic body radiation therapy to the central hepatobiliary tract.
    Osmundson EC; Wu Y; Luxton G; Bazan JG; Koong AC; Chang DT
    Int J Radiat Oncol Biol Phys; 2015 Apr; 91(5):986-94. PubMed ID: 25659885
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy and safety of hypofractionated stereotactic radiotherapy for brain metastases using three fractions: A single-centre retrospective study.
    Vigneau E; Jacquemin J; Benadon B; Dat Nguyen T; Marchand-Créty C
    Cancer Radiother; 2021 Dec; 25(8):763-770. PubMed ID: 34083125
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phase I dose escalation study of helical intensity-modulated radiotherapy-based stereotactic body radiotherapy for hepatocellular carcinoma.
    Kim JW; Seong J; Lee IJ; Woo JY; Han KH
    Oncotarget; 2016 Jun; 7(26):40756-40766. PubMed ID: 27213593
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chest wall toxicity after hypofractionated proton beam therapy for liver malignancies.
    Yeung R; Bowen SR; Chapman TR; MacLennan GT; Apisarnthanarax S
    Pract Radiat Oncol; 2018; 8(4):287-293. PubMed ID: 29452863
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Hepatic tumors and radiotherapy].
    Rio E; Mornex F; Peiffert D; Huertas A
    Cancer Radiother; 2016 Sep; 20 Suppl():S174-8. PubMed ID: 27521035
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dosimetric analysis of stereotactic rotational versus static intensity-modulated radiation therapy for pancreatic cancer.
    Cho I; Park JW; Cho B; Kwak J; Yoon SM; Nesseler JP; Park J; Kim JH
    Cancer Radiother; 2018 Dec; 22(8):754-762. PubMed ID: 30322818
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dosimetric predictors of radiation-induced lung injury in stereotactic body radiation therapy.
    Ricardi U; Filippi AR; Guarneri A; Giglioli FR; Mantovani C; Fiandra C; Anglesio S; Ragona R
    Acta Oncol; 2009; 48(4):571-7. PubMed ID: 19031164
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Robotic stereotactic body radiation therapy for tumors of the liver: radiation-induced liver disease, incidence and predictive factors.
    Janoray G; Chapet S; Ruffier-Loubière A; Bernadou G; Pointreau Y; Calais G
    Cancer Radiother; 2014 Jun; 18(3):191-7. PubMed ID: 24837351
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of Stereotactic Body Radiation Therapy Combined With or Without Transcatheter Arterial Chemoembolization for Patients With Small Hepatocellular Carcinoma Ineligible for Resection or Ablation Therapies.
    Kimura T; Aikata H; Doi Y; Imano N; Takeuchi Y; Takahashi I; Nishibuchi I; Katsuta T; Kenjo M; Murakami Y; Awai K; Chayama K; Nagata Y
    Technol Cancer Res Treat; 2018 Jan; 17():1533033818783450. PubMed ID: 29963972
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of stereotactic body radiation therapy in liver metastasis: A pilot study from tertiary cancer institute in India.
    Kumar S; Kapoor R; Oinam AS; Kalra N; Duseja A
    J Cancer Res Ther; 2019; 15(1):169-175. PubMed ID: 30880775
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.